| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.033 | 0.8 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | -0.0076 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.8 |